Safety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy

This was a prospective, repeat-treatment, open-label study (NCT01251380) of abobotulinumtoxinA for the management of lower limb spasticity in children who had completed a double-blind study. Children (2-17 years) received injections into the gastrocnemius-soleus complex, and other distal and proxima...

Descripción completa

Detalles Bibliográficos
Autores principales: Delgado, Mauricio R., Bonikowski, Marcin, Carranza, Jorge, Dabrowski, Edward, Matthews, Dennis, Russman, Barry, Tilton, Ann, Velez, Juan Carlos, Grandoulier, Anne-Sophie, Picaut, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652649/
https://www.ncbi.nlm.nih.gov/pubmed/28914131
http://dx.doi.org/10.1177/0883073817729918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652649/
https://www.ncbi.nlm.nih.gov/pubmed/28914131
http://dx.doi.org/10.1177/0883073817729918

Ejemplares similares